Cargando…
Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
Both CD5 and CD43 are expressed on the surface of B lymphocytes of definite phase and associated with the adverse outcome in diffuse large B‐cell lymphoma (DLBCL). However, the relationship between CD5 and CD43 expression and the prognostic value of CD5/CD43 coexpression in DLBCL are unknown. We her...
Autores principales: | Ma, Xiao‐bo, Zhong, Yan‐ping, Zheng, Yan, Jiang, Jing, Wang, Yin‐ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144247/ https://www.ncbi.nlm.nih.gov/pubmed/30019388 http://dx.doi.org/10.1002/cam4.1674 |
Ejemplares similares
-
PD‐1 expression on the surface of peripheral blood CD4(+) T cell and its association with the prognosis of patients with diffuse large B‐cell lymphoma
por: Zhang, Wei, et al.
Publicado: (2016) -
Phase II trial of co‐administration of CD19‐ and CD20‐targeted chimeric antigen receptor T cells for relapsed and refractory diffuse large B cell lymphoma
por: Sang, Wei, et al.
Publicado: (2020) -
Atypical CD5 and CD10 coexpression in a splenic marginal zone lymphoma
por: Gimenez De Mestral, Santiago, et al.
Publicado: (2021) -
Clinicopathological analysis of primary intestinal diffuse large B‐cell lymphoma: Prognostic evaluation of CD5, PD‐L1, and Epstein‐Barr virus on tumor cells
por: Ishikawa, Eri, et al.
Publicado: (2018) -
The Influence of the Coexpression of CD4 and CD8 in Cutaneous Lesions on Prognosis of Mycosis Fungoides: A Preliminary Study
por: De Marchi, Sergio Umberto, et al.
Publicado: (2014)